Characterizing expanded access and compassionate use programs for experimental drugs

Overview of attention for article published in BMC Research Notes, July 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 4,524)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 53 news outlets
blogs: 2 blogs
twitter: 29 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 60 Mendeley

Summary News Blogs X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 public wall post.

Bioethics International, 28 Jul 2017

76% experimental drugs provided in registered #ExpandedAccess programs rcv #FDA approval #rightotry @BioMedCentral https://t.co/f…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.